MENA 2024 Recordings-Osteoporosis in Men MTE2B

Video Transcription

Video Summary

The video addresses osteoporosis in men, highlighting that skeletal health challenges in men are comparable to cardiovascular issues in women. Men's bone density declines roughly a decade later than women's, but they face higher risks of mortality, refracture, and morbidity following fractures. The video discusses the epidemiology of osteoporosis and presents specific cases involving men's fracture risks. It emphasizes that men experience a gradual decline in bone density, predominantly after age 65 or 70, leading to increased risks of hip and vertebral fractures later in life. Factors contributing to bone density loss include increased osteoclast activity and decreased osteoblast formation. In men undergoing androgen deprivation therapy for prostate cancer, there is a notable rapid bone density loss, requiring potential intervention with agents like zoledronate or denosumab to mitigate fracture risks. The presentation calls for improved osteoporosis screening in men, often hindered by reimbursement issues. Additionally, it covers case studies to illustrate clinical decision-making and treatment strategies, recommending medications and physical therapy to improve outcomes and prevent further fractures.

Asset Subtitle

Dr Jad Sfeir

Keywords

osteoporosis

men's skeletal health

bone density decline

fracture risks

androgen deprivation therapy

osteoporosis screening

treatment strategies